Ncardia

After the growth of our US based team this year, we've realized that having an international team means adapting across time zones and cultures, but it's all worth it to give the best support to our clients. Each day, we embrace flexibility and learn from one another, proving that diversity drives innovation. Together, we're stronger and more dynamic! #GlobalTeam #AdaptAndThrive #Ncardia

WEBINAR on ALS Next Week! Join us for an insightful session with Kimberley Riegman, PhD as she introduces our powerful and miniaturized assay for screening ALS therapeutics. Get ready for quick results and a broad range of disease-relevant readouts, helping you speed up and confidently choose the best drug candidates for ALS. Don't miss out on this chance to learn from an expert in the field! We have two sessions available to fit your schedule: For our European audience: July 30 at 3 PM CEST Register here: https://lnkd.in/dB2ATriD For our US audience: July 31 at 1 PM ET Register here: https://lnkd.in/dXMdaPiT Secure your spot and gain valuable insights! #Webinar #Neurobiology #ALSResearch #CellBasedAssay #Ncardia

Did you know? Ncardia has integrated the cutting-edge STAR-CRISPR technology which is revolutionizing gene editing of iPSCs. This breakthrough offers unparalleled efficiency for gene knock-in and knock-out while minimizing off-target effects in iPSCs. Discover how STAR-CRISPR technology is now integrated as part of Ncardia's custom supply services. Read the full blog here: https://lnkd.in/duBXfcgV #GeneEditing #CRISPR #Ncardia #stemcell

WEBINAR on ALS! Join us for an insightful session with Kimberley Riegman, PhD about our robust and miniaturized assay to screen ALS therapeutics. With a quick turnaround and a wide range of disease-relevant readouts you can move faster and confidently in the selection of drug candidates for ALS. Two Sessions Available! Don't miss this opportunity to learn from an expert in the field! Register for the session that best fits your schedule here: For our European audience: July 30 at 3 PM CEST https://lnkd.in/damqdqtv For our US audience: July 31 at 1 PM ET https://lnkd.in/dQ-NT_PP #Webinar #Neurobiology #ALSResearch #cellbasedassay #Ncardia

CASE STUDY: An example of how large-scale generation of iPSC-derived models can be streamlined to success. This study by Karin Langenberg shows how we developed a scalable process for skeletal muscle cells, highlighting a cost-efficient approach and the use of high-content imaging for quality assessment. Enhance your understanding of iPSC technology and its applications to advance therapeutic research. Download the full case study here: https://lnkd.in/dpBqEsBQ #Ncardia #iPSC #CaseStudy

Are you attending ISCCR 2024? If so, don't miss our Poster #300 today from 6:45 to 7:45 PM. In collaboration with Leiden University Medical Center this poster showcases the latest innovations with 3D cardiac microtissues, calcium imaging and high-throughput screening. You can also schedule a meeting with Charles Leach if that fits your schedule better. Click the link to book your meeting: https://lnkd.in/dE8_qdce. See you there! #ISSCR2024 #PosterSession #ScientificResearch

Latest news from our Divisional CEO! Read this interview to gain insights into Ncardia's strategic plan and get a sneak peek into upcoming innovation projects and goals. After a first half year with us, Jeroen De Groot talks about the progress of the company and its future mission. Check it out now: https://lnkd.in/dCgmp4CB Join us on this path to innovation! #iPSC #DrugDiscovery #CellTherapy #Innovation #Ncardia

Happy 4th of July from Ncardia! Warm wishes to our American colleagues and clients. Enjoy a joyful Independence Day filled with celebrations, fireworks, and great company. Let's honor the spirit of freedom and unity that makes this day special. #July4th #Ncardia #USA

ALS researchers! Are you looking for clinically relevant readouts in your cell-based screenings? Learn how to study ALS-relevant readouts, including TDP-43 mis-localization and aggregation, STMN2 protein level reduction, NfL secretion, and more, with our iPSC-based platform based on robust and ready-to-scale phenotypic assays. Discover how this platform is already helping advance new ALS therapeutics. Download now: https://lnkd.in/deha3be8 #ALSResearch #iPSC #Ncardia

Did you miss our webinar on HSC manufacturing? No worries! It's now available on-demand. Watch Now: https://lnkd.in/dydA2bPi This is your chance to gain insights from leading industry experts and discover an efficient approach for large-scale process development. In this webinar, you will: - Learn strategies to mitigate risks and accelerate process development using advanced data science. - Discover how to easily incorporate GMP-compliant processes early in cell therapy development. - Understand how robust processes can boost confidence in the early stages of developing new therapeutics. #webinar #iPSC #HSC #processdevelopment